Lorenzo, R. B., L. S. Lorenzo, and A. González-Martín. “Will the Carboplatin-Paclitaxel-Bevacizumab Combination Become the Preferred Option As the First Line in Advanced Cervical Cancer? A Small Experience from a Single Oncologic Center:  ”. Cancer Breaking News, vol. 5, no. 1, Apr. 2017, pp. 21-24, doi:10.19156/cbn.2017.0035.